Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria

B Banwell, JL Bennett, R Marignier, HJ Kim… - The Lancet …, 2023 - thelancet.com
Serum antibodies directed against myelin oligodendrocyte glycoprotein (MOG) are found in
patients with acquired CNS demyelinating syndromes that are distinct from multiple sclerosis …

2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis

MP Wattjes, O Ciccarelli, DS Reich, B Banwell… - The Lancet …, 2021 - thelancet.com
Summary The 2015 Magnetic Resonance Imaging in Multiple Sclerosis and 2016
Consortium of Multiple Sclerosis Centres guidelines on the use of MRI in diagnosis and …

Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines

M Filippi, P Preziosa, BL Banwell, F Barkhof… - Brain, 2019 - academic.oup.com
MRI has improved the diagnostic work-up of multiple sclerosis, but inappropriate image
interpretation and application of MRI diagnostic criteria contribute to misdiagnosis. Some …

Spinal cord atrophy predicts progressive disease in relapsing multiple sclerosis

A Bischof, N Papinutto, A Keshavan… - Annals of …, 2022 - Wiley Online Library
Objective A major challenge in multiple sclerosis (MS) research is the understanding of
silent progression and Progressive MS. Using a novel method to accurately capture upper …

Differentiating multiple sclerosis from AQP4-neuromyelitis optica spectrum disorder and MOG-antibody disease with imaging

R Cortese, F Prados Carrasco, C Tur, A Bianchi… - Neurology, 2023 - AAN Enterprises
Background and Objectives Relapsing-remitting multiple sclerosis (RRMS), aquaporin-4
antibody–positive neuromyelitis optica spectrum disorder (AQP4-NMOSD), and myelin …

Re-examining the role of TNF in MS pathogenesis and therapy

D Fresegna, S Bullitta, A Musella, FR Rizzo, F De Vito… - Cells, 2020 - mdpi.com
Multiple sclerosis (MS) is a common neurological disorder of putative autoimmune origin.
Clinical and experimental studies delineate abnormal expression of specific cytokines over …

Latin American consensus recommendations for management and treatment of neuromyelitis optica spectrum disorders in clinical practice

EC Contentti, JI Rojas, E Cristiano, VD Marques… - Multiple sclerosis and …, 2020 - Elsevier
Background During the last two decades, neuromyelitis optica spectrum disorder (NMOSD)
has undergone important changes, with new diagnostic markers and criteria, better …

Myelitis and other autoimmune myelopathies

SL Chiriboga, EP Flanagan - CONTINUUM: Lifelong Learning in …, 2021 - journals.lww.com
PURPOSE OF REVIEW This article provides an update on the clinical diagnosis and
management of immune-mediated myelopathies, including the relevance of imaging …

Myelitis features and outcomes in CNS demyelinating disorders: comparison between multiple sclerosis, MOGAD, and AQP4-IgG-positive NMOSD

G Fadda, EP Flanagan, L Cacciaguerra… - Frontiers in …, 2022 - frontiersin.org
Inflammatory myelopathies can manifest with a combination of motor, sensory and
autonomic dysfunction of variable severity. Depending on the underlying etiology, the …

Advances in spinal cord imaging in multiple sclerosis

M Moccia, S Ruggieri, A Ianniello… - Therapeutic …, 2019 - journals.sagepub.com
The spinal cord is frequently affected in multiple sclerosis (MS), causing motor, sensory and
autonomic dysfunction. A number of pathological abnormalities, including demyelination …